NSABP Foundation Inc.
Randy Poljak, CPA has extensive work experience in accounting and financial reporting. Randy most recently served as the Director of Accounting at NSABP Foundation Inc. since March 2022. Prior to that, Randy worked at Gateway Health, where they held various roles including Manager of Financial Accounting and Reporting, Financial Reporting Supervisor, Lead Accountant, and Senior Accountant from 2016 to 2022. Before joining Gateway Health, Randy worked at Inpoint, an Aon company, as a Senior Accountant and Staff Accountant from 2006 to 2016. At Inpoint, they managed monthly accounting and reporting for financial outsourcing clients, assisted in the monthly close process, and completed GAAP/STAT reporting. Randy also held the position of Accounting Analyst, where they reported monthly revenue and expense figures and worked on various projects such as expense and margin analysis.
Randy Poljak, CPA has a solid education background. Randy obtained a Bachelor of Science (BS) degree in Accounting from Penn State University, where they studied from 1999 to 2003. To further enhance their knowledge and skills in business, they pursued a Master of Business Administration (M.B.A.) degree from Robert Morris University from 2011 to 2013.
In addition to their academic achievements, Randy Poljak also holds a certification as a Certified Public Accountant (CPA) issued by the State Board of Accountancy.
NSABP Foundation Inc.
Partners in Cancer Research… The NSABP Foundation is a not-for-profit academic research organization with a nearly 60-year history of conducting ground-breaking research studies in breast and colorectal cancer. Our goal is to improve outcomes for cancer patients via improved therapeutic and prevention modalities. Over the past 15 years we have established full-service capabilities to conduct independently funded international research with the private sector to evaluate promising new agents and now offer a wide range of capabilities, from pre-clinical research through phase III clinical trials focused on biomarker-driven studies. In its history the NSABP has enrolled more than 110,000 women and men in clinical trials in breast and colorectal cancer. We have research sites at nearly 700 major medical centers, university hospitals, large oncology practice groups, and health maintenance organizations in the United States, Canada, and Ireland. At those sites and their satellites, about 5000 physicians, nurses, and other medical professionals conduct NSABP treatment and prevention trials. The NSABP Foundation, located at Nova Place in Pittsburgh, Pennsylvania, carries on the legacy of the National Surgical Adjuvant Breast and Bowel Project in clinical studies done in partnership with industry.